View all news

    Janssen Seeks to Expand Use of TREMFYA®▼ (guselkumab) in the Treatment of Adults with Active Psoriatic Arthritis

    10/23/2019
    Download(opens in new window)PDF 444 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com